✦ LIBER ✦

Functions of 5-HT2A receptor and its antagonists in the cardiovascular system

✍ Scribed by Takafumi Nagatomo; Mamunur Rashid; Habib Abul Muntasir; Tadazumi Komiyama

Book ID: 113845569
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 664 KB
Volume: 104
Category: Article
ISSN: 0163-7258
DOI: 10.1016/j.pharmthera.2004.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Functional subsensitivity of 5-HT2A and

Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists

✍ P. Mazzola-Pomietto; Charanjit S. Aulakh; Teresa Tolliver; Dennis L. Murphy 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 910 KB

Restraint accentuates the effects of 5-H

Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior

✍ Lynda Uphouse; Stacy White; Lance Harrison; Cindy Hiegel; Devi Majumdar; Jutatip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 314 KB

The 5-HT4 receptor agonist, tegaserod, i

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

✍ D T Beattie; J A M Smith; D Marquess; R G Vickery; S R Armstrong; T Pulido-Rios; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 298 KB

Preclinical profile of the mixed 5-HT1A/

Preclinical profile of the mixed 5-HT1A/5-HT2A receptor antagonist S 21357

✍ Guy Griebel; D.Caroline Blanchard; Marie-Claire Rettori; Béatrice Guardiola-Lema 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 982 KB

The role of 5-HT2A receptor and 5-HT2A/5

The role of 5-HT2A receptor and 5-HT2A/5-HT1A receptor interaction in the suppression of catalepsy

✍ V. S. Naumenko; D. V. Bazovkina; E. M. Kondaurova; E. A. Zubkov; A. V. Kulikov 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 581 KB

Neurochemical profile in vitro of irinda

Neurochemical profile in vitro of irindalone: A5-HT2-receptor antagonist

✍ John Hyttel; Klaus BøGesø; Hanne LøVe LembøL; Jens-JøRgen Larsen; Eddi Meier 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 866 KB

A new potential antihypertensive drug, irindalone (Lu 21 -098;( +)-(1 R,3S)-1-[2-[4-[3-(pf luoropheny1)-1 -indanyl]-1 -piperazinyl]ethyl]-2-imidazolidinone), has been characterized by a series of in vitro methods. lrindalone competitively inhibits peripheral and central serotonin;! (5-HT2) receptors